Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Talley RW"'
Publikováno v:
AMERICAN JOURNAL OF CLINICAL ONCOLOGY. 5:631-634
Thirty-four assessable patients with advanced squamous cell and adenocarcinoma of the lung were treated with weekly MGBG in a phase II trial. Only one partial response, in adenocarcinoma, was observed. Myelosuppression was mild to moderate. Major tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1776a531f57898be24c38475880ca996
https://doi.org/10.1097/00000421-198212000-00010
https://doi.org/10.1097/00000421-198212000-00010
Autor:
Vainutis K. Vaitkevicius, Laurence H. Baker, B. W. Ruffner, Edmund A. Gehan, Daniel E. Lehane, Ronald L. Stephens, Francis S. Morrison, Richard Matter, Stephen E. Jones, Talley Rw
Publikováno v:
Cancer. 38:1-7
In a randomized and stratified study, 294 patients with advanced gastrointestinal cancer were treated either with 5-fluorouracil (5-FU) 400 mg/m2 weekly intravenously (i.v.) or 5-FU 400 mg/m2 i.v. weekly plus methyl-CCNU 175 mg/m2 orally (p.o.) every
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caa450728c9a1ade213175805d75f71d
https://doi.org/10.1002/1097-0142(197607)38:1<1::aid-cncr2820380102>3.0.co
https://doi.org/10.1002/1097-0142(197607)38:1<1::aid-cncr2820380102>3.0.co
Autor:
Laurence H. Baker, Fraile Rj, Robert W. Brownlee, Ahmad M. Samhouri, Michael K. Samson, Talley Rw
Publikováno v:
European Journal of Cancer (1965). 17:337-343
A phase II evaluation of chlorozoticin (CZT), a water soluble nitrosourea, was undertaken to determine its effectiveness and toxicity in a variety of human metastatic neoplasms. The dosage regimen chosen was either 90 or 120 mg/m 2 given by i.v. bolu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abfc967762ad028d5a7ccad2d6c4a5c
https://doi.org/10.1016/0014-2964(81)90125-0
https://doi.org/10.1016/0014-2964(81)90125-0
Publikováno v:
American Journal of Clinical Oncology. 6:369-374
Cis-platinum plus high-dose methotrexate with citrovorum factor rescue underwent an initial evaluation of toxicity in patients with pelvic or abdominal adenocarcinoma and a subsequent efficacy trial in proven ovarian cancers. Forty-five patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8d336a1b524441cf1299f86ac75672
https://doi.org/10.1097/00000421-198306000-00019
https://doi.org/10.1097/00000421-198306000-00019
Autor:
Vainutis K. Vaitkevicius, Eugene M. McKelvey, Thomas E. Moon, Gerald P. Bodey, Montague Lane, James K. Luce, Talley Rw
Publikováno v:
Cancer. 39:5-10
One hundred twenty-one patients with disseminated malignant melanoma were treated with BCNU, vincristine, DTIC, and chlorpromazine (BVD). A response rate of 22% was observed; 28% of the patients had stable disease and 50% had increasing disease. Simi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::263db5f1ad6e0ad56c4e24b77dddcb88
https://doi.org/10.1002/1097-0142(197701)39:1<5::aid-cncr2820390103>3.0.co
https://doi.org/10.1002/1097-0142(197701)39:1<5::aid-cncr2820390103>3.0.co
Publikováno v:
European journal of cancer. 14(12)
Fifty-five evaluable patients with advanced carcinoma of the lung ( 25 squamous, 19 adeno, 11 small cell) and 16 patients with advanced adenocarcinoma of the ovary were treated with VM 26 in a phase II study. Only one response was noted, a partial (>
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b02279688616036725efe799387ffc5
https://pubmed.ncbi.nlm.nih.gov/216556
https://pubmed.ncbi.nlm.nih.gov/216556
Publikováno v:
Southern medical journal. 45(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0f04925d0dea437317164ba1027eae
https://pubmed.ncbi.nlm.nih.gov/14931034
https://pubmed.ncbi.nlm.nih.gov/14931034
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer chemotherapy reports [Cancer Chemother Rep] 1975 Mar-Apr; Vol. 59 (2 Pt 1), pp. 425-7.
Publikováno v:
Cancer treatment reports [Cancer Treat Rep] 1981 Jul-Aug; Vol. 65 (7-8), pp. 655-8.